UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:December 08,
vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more vTv Therapeutics Charts.
vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more vTv Therapeutics Charts.

Vtv Therapeutics Inc. News

CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
Tuesday 19 March 2024 (2 months ago) • PR Newswire (US)
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 3 - Initial statement of beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 13D - General statement of acquisition of beneficial ownership
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
Saturday 2 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.
CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE
Friday 23 February 2024 (2 months ago) • PR Newswire (US)

More Vtv Therapeutics Inc. News Articles